Member of
Contributors
Publisher
Florida Atlantic University
Date Issued
2008
EDTF Date Created
2008
Description
Compositions and methods for reducing neovascularization.
Purified nucleic acid constructs and vectors encoding an antiangiogenic
protein operably linked to a GFAP promoter. Vectors
can include at least one hypoxia regulated element,
enhancer element and silencer element. Gene therapy methods
for reducing, delaying or preventing neovascularization
based on the nucleic acid constructs and vectors.
Purified nucleic acid constructs and vectors encoding an antiangiogenic
protein operably linked to a GFAP promoter. Vectors
can include at least one hypoxia regulated element,
enhancer element and silencer element. Gene therapy methods
for reducing, delaying or preventing neovascularization
based on the nucleic acid constructs and vectors.
Language
Type
Genre
Form
Extent
28 p.
Identifier
FAUIR000259
Date Backup
2008
Date Created Backup
2008
Date Text
2008
Date Created (EDTF)
2008
Date Issued (EDTF)
2008
Extension
FAU
IID
FAUIR000259
Organizations
Attributed name: Florida Atlantic University
Attributed name: Prentice, Howard
Person Preferred Name
Dorey, C. Kathleen
author
Physical Description
application/pdf
28 p.
Title Plain
GFAP-Based Gene Therapy for Treatment of Retinal Diseases, 2008
Use and Reproduction
All rights reserved by the source institution
Origin Information
2008
2008
Florida Atlantic University
Boca Raton, FL
Place
Boca Raton, FL
Title
GFAP-Based Gene Therapy for Treatment of Retinal Diseases, 2008
Other Title Info
GFAP-Based Gene Therapy for Treatment of Retinal Diseases, 2008